Copd
44% of patients with acute exacerbations of COPD have hypogammaglobulinemia
SAN DIEGO — Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple therapy, according to a presentation here.
COPD inhaler adherence rises with lower cost sharing, medication management service invite
Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results published in JAMA Internal Medicine.
Q&A: Lung inflammation decreases with form of vitamin B3 in COPD
Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung inflammation, according to results published in Nature Aging.
Individuals with impaired FEV1/FVC trajectories often experience wheeze before middle age
Around 20% to 25% of individuals with rapidly declining FEV1/FVC trajectories experienced wheezing and usual phlegm/bronchitis as adolescents/young adults, according to results published in The Lancet Respiratory Medicine.
SGLT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers reported.
Genetic risk score plus lung function questionnaire improves COPD prediction
The ability to predict spirometry-defined COPD was significantly better when a modified lung function questionnaire score was used in combination with a COPD polygenic risk score, according to results published in JAMA.
Odds for injurious fall heightened with fall-risk increasing drug prescription in COPD
The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
Smoking before age 15 years raises COPD risk in adulthood regardless of smoking factors
The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
CDC: Chronic lower respiratory diseases rank sixth on 2022 top causes of death
In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published in National Vital Statistics Reports.
Risk for cardiovascular events stays high 1 year after COPD exacerbation
Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results.